Friday, November 15, 2024

Search Results

Rational Vaccines Announces a Clinical Study of the Frequency of Symptomatic Herpes Simplex Type 1 and 2 (HSV-1 and HSV-2) Virus in HIV Patients

Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, announced the launch of a clinical trial...

Palo Alto Networks joins the Nasdaq-100

Palo Alto Networks the global cybersecurity leader, shared that it has joined the Nasdaq-100® Index, the top 100 largest domestic and international non-financial companies...

Proterra announces EV battery factory in South Carolina as demand for commercial electric vehicles grows

As demand for commercial electric vehicles continues to grow across the United States and around the world, Proterra Inc, a leading innovator in commercial...

ImmunoGenesis Appoints Oncology Research Veteran to Lead Immuno-Oncology Clinical Development Targeting Immune-Excluded, “Cold” Cancers

ImmunoGenesis, a clinical-stage biotechnology company developing science-driven immune therapies, announced the appointment of seasoned industry veteran Charles Schweizer, PhD, as Senior Vice President of...

New Drug Combo May Improve Family-donated Stem Cells as Blood Cancer Treatment

A drug combination can safely prevent transplanted stem cells (graft) from attacking the recipient's (host) body, allowing them to develop into healthy new blood...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics